Cancer Testing/Screening Market – By Techniques-Biomarker Test (PSA, CTC, AFP Tests); By Imaging (MRI Scan, CT Scan), By Technologies (NGS, QPCR, IHC), Applications, Geography – Forecasts 2016 – 2021. – Biomarkers, Biotechnology, Healthcare Industries

The Cancer Testing/Screening Market – By Techniques-Biomarker Test (PSA, CTC, AFP Tests); By Imaging (MRI Scan, CT Scan), By Technologies (NGS, QPCR, IHC), Applications, Geography – Forecasts 2016 – 2021. Report has been published. It provides updated in 2018 year analysis of industries from Biomarkers, Biotechnology, Healthcare Markets.

Cancer is a group of diseases, which involves the abnormal cell growth with the ability or the potential to spread to the other parts of the body. These cells form a neoplasm, where neoplasm or tumor is a group of cells that will undergo an unregulated growth. There are over 100 different known cancers that affect humans. The cancer screening or cancer testing, targets to detect the cancer before symptoms appear and also before it starts to spread throughout the body. Screening tests must be accurate and effectively appropriate in order to perform the necessary diagnosis. The most common sites of cancer among men are lung, prostate, colon, rectum, stomach and liver. The most common sites of cancer among women are breast, colon, rectum, lung, cervix and stomach.

The market for the cancer screening is found to be valued at $XX billion in 2015. At the end of 2015, the market is estimated to be $XX billion and is estimated to reach around $XX billion by 2021, growing at a CAGR of XX% from 2016 to 2021. This scenario is expected to further revolutionize the industry towards massive growth in the next 5 to 10 years because of the technological advancements and developments in the medicines in cancer diagnosis and effective health care.

Though the cost of diagnosis is one of the main constraints, government support and indigenous technologies from countries such China, India, and Japan is helping the market penetration. A simple blood test could be on the way to replacing the biopsy as the gold standard for detecting cancer, saving lives and money, according to researchers in the U.K. In their study, carried out on known or suspected primary or secondary lung cancer who were about to undergo surgery, the blood test was accurate in predicting the presence of cancer cells in nearly 70% of cases.

The above table explains the classification of cancer testing techniques which healthcare systems follow or usually doctors follow depending upon the type of cancer or techniques or by operation or selection of particular technique depending upon the stage of cancer. The stages of cancer refer to the severity of tumor or the time period from which it’s been affecting the human body.

The major cause for the cancer is smoking and tobacco consumption and there are over 100 varieties of cancer depending upon various factors like the body part to which it is affected such as lung cancer, blood cancer, cervical cancer, breast cancer, abdominal cancer and screening techniques can be classified depending upon the type it is going to be diagnosed or may be depending upon the procedure which the particular method they follow such as imaging techniques (Computed tomography (CT) scan, Magnetic resonance imaging (MRI) scan, X-rays and other radiographic tests, Mammography, Ultrasound), endoscopy (arthroscopy, nronchoscopy, nystoscopy, laparoscopy, neuroendoscopy), bio marker tests, and also based on the technologies which the process follow and also on the treatment which they follow such as surgery, radiation, chemotherapy, immunotherapy, hormone therapy, gene therapy.

The high cancer rate is observed in countries such as Denmark, Australia, Belgium, Norway, Ireland, and North Korea whereas the low cancer rate is found in Niger, Columbia, Nepal, Namibia, and Bhutan etc. The most widely affected cancer areas where these cancer-testing techniques are followed can be segmented based on the geography such as Europe, America, APAC, and RoW can be segmented whereas the major portion is occupied by the Europe followed by Americas followed by APAC countries.

Please Note: The report is to be delivered in 1-2 working days after an order is placed.

Read more and order at Cancer Testing/Screening Market – By Techniques-Biomarker Test (PSA, CTC, AFP Tests); By Imaging (MRI Scan, CT Scan), By Technologies (NGS, QPCR, IHC), Applications, Geography – Forecasts 2016 – 2021.

US Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities – Biomarkers, Biotechnology, Healthcare Industries

The US Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities Report has been published. It provides updated in 2018 year analysis of industries from Biomarkers, Biotechnology, Healthcare Markets.

This new report contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including:

  • Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Test volume and sales forecasts for 40 tumor markers performed in US hospitals.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains 567 pages and 50 tables

Read more and order at US Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

2017 Global Tumor Marker Testing Market: Test Volume and Sales Forecasts by Country – Biomarkers, Biotechnology, Healthcare Industries

The 2017 Global Tumor Marker Testing Market: Test Volume and Sales Forecasts by Country Report has been published. It provides updated in 2018 year analysis of industries from Biomarkers, Biotechnology, Healthcare Markets.

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country.

Contains 11 pages and 3 tables

Read more and order at 2017 Global Tumor Marker Testing Market: Test Volume and Sales Forecasts by Country

World Bioburden Testing Market – Opportunities and Forecasts, 2014 – 2022 – Biotechnology, Healthcare Industries

The World Bioburden Testing Market – Opportunities and Forecasts, 2014 – 2022 Report has been published. It provides updated in 2018 year analysis of industries from Biotechnology, Healthcare Markets.

Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices. It further aids in routine monitoring of raw material, components, and assembly processes in manufacturing process. The bioburden testing is used for assessment of cleaning processes and packaging of products is conducted to ensure safety.

Growth in the medical devices, pharmaceutical and rising product recalls due to microbial contamination are factors that drive the growth of the world bioburden testing market. In addition, biotechnology industries and increasing food & beverage safety concerns supplements growth. However, high cost of microbial enumeration instruments obstructs the growth of the market. Increasing preference for contract manufacturing and emerging economies are creating opportunities in the market.

The world bioburden testing market is segmented into product, test, application, end user, and geography. The product segment is further classified into instruments and consumables. The instruments covered in the report are PCR and microscopes. While, consumables included in the report are kits and reagents. The tests are further classified into aerobic, anaerobic, fungi, and spore. The application segment is further classified into raw material and in-process applications. The end users included in the report are pharmaceutical, biotechnology, and CMO. Geographically, the market is segmented into North America, Asia, Europe, and Latin America, Middle East and Africa (LAMEA).

The prominent companies operating in the market are Charles River Laboratories International Inc., Sigma-Aldrich Corporation, SGS S.A., Wuxi Pharmatech (CAYMAN) Inc., Merck & Co. Inc., Becton, Dickinson, and Company, North American Science Associates Inc., Nelson Laboratories Inc., Pacific Biolabs, and ATS Labs Inc. They have formulated strategies such as partnerships, collaborations, mergers & acquisitions, joint ventures, expansions, and others to sustain in the market.

KEY BENEFITS FOR STAKEHOLDERS:

The report offers a detailed analysis of key driving and restraining factors of the world bioburden testing market.
The report provides an extensive analysis of current and future market status of the world bioburden testing market.
This report offers an in-depth quantitative analysis of the current market and estimations through 2015-2020, which assists in identifying the prevailing market opportunities.
An exhaustive analysis of key strategies adopted by leading manufacturers helps in understanding competitive scenario.
Comprehensive analysis has been done in this report by constructing market estimations for the key market segments between 2015 and 2020.
An extensive analysis of current research and clinical developments withinthe world bioburden testing market is provided with key market dynamic factors that help in understanding the behaviour of the market.
The world bioburden testing market is segmented into North America, Asia, Europe, and Latin America, Middle East and Africa (LAMEA).

KEY MARKET SEGMENTS:

By Product

Instruments

PCR
Microscopes

Consumables

Kits
Reagents

By Test

Aerobic
Anaerobic
Fungi
Spore

By Application

Raw Material
In-Process

By End User

Pharmaceutical
Biotechnology
CMO

By Geography

North America
Asia
Europe
Latin America, Middle East and Africa (LAMEA)

Key Market Players:

Charles River Laboratories International Inc.
Sigma-Aldrich Corporation
SGS S.A.
Wuxi Pharmatech (CAYMAN) Inc.
Merck & Co. Inc.
Becton, Dickinson, and Company
North American Science Associates Inc.
Nelson Laboratories Inc.
Pacific Biolabs
ATS Labs Inc.

This report will be dispatched in 10 days after purchase.

Read more and order at World Bioburden Testing Market – Opportunities and Forecasts, 2014 – 2022

Cell Expansion Technologies and Global Markets – Biotechnology, Healthcare Industries

The Cell Expansion Technologies and Global Markets Report has been published. It provides updated in 2018 year analysis of industries from Biotechnology, Healthcare Markets.

This report covers the global cell expansion market and its segments, which include cell type, products, applications, end-user markets and geographic segmentation. Forecasts are provided through 2020.

This report provides:

– An overview of the global markets for cell expansion, mainly categorized into two major types, animal cells and human cells
– Analyses of global market trends, with data for 2014, estimates for 2015, and projections of CAGRs through 2020
– Geographical breakdown across: North America, Europe, Asia-Pacific and ROW
– Analysis of applications including clinical diagnostics, drug discovery and development, regenerative medicine and others
– Coverage of automated cell expansion systems, bioreactors, and cell expansion supporting equipment
– Coverage of consumables including reagents, media, & sera and disposables
– Profiles of major players in the industry

Scope of the Report:

On the basis of cell type, the cell expansion market is divided into two major types: animal cells and human cells. Animal cell expansion in this report includes various cells such as embryonic stem cells and mesenchymal stem cells (MSC). Furthermore, the human cells used in cell expansion are classified as stem cells and differentiated cells. These cell types are used in applications such as diagnostics, drug discovery and development, regenerative medicine and others. The end users of this market are hospitals and diagnostic centers, research institutes and academics, and bio-pharmaceutical and biotechnology companies. Cell expansion applications are analyzed in detail in the report with their potential scope and opportunities throughout the forecast period.

The global cell expansion product market is segmented into three major categories: consumables, instruments and cell expansion supporting equipment. The consumables category consists of reagents, media, and sera and disposables. The instrument category is comprised of automated cell expansion systems and bioreactors. The cell expansion supporting equipment category is comprised of centrifuges, flow cytometers, filtration systems, microscopes, incubators, laminar air flow cabinets and other equipment. By geography, the market segments are North America, Europe, Asia-Pacific and ROW.

Highlights:

– The global cell expansion market generated revenue of roughly $8.5 billion in 2014, and is expected to reach revenues of $9.7 billion in 2015 and $22.0 billion by 2020, with a compound annual growth rate (CAGR) of 17.8% from 2015 to 2020.
– North America is the largest revenue-generating region of the cell expansion market, accounting for $3.7 billion in 2014. This market is expected to increase from $4.2 billion in 2015 to nearly $9.2 billion by 2020, a CAGR of 16.7% from 2015 to 2020.
– The Asia-Pacific cell expansion market accounted for $919 million in 2014, and is expected to reach nearly $1.1 billion in 2015 and $3.0 billion by 2020, growing at a CAGR of 22.2% from 2015 to 2020.

Use this report to:

– Identify key market segments and the market's structure regarding cell expansion technologies.
– Analyze key market dynamics and the factors impacting the global cell expansion market and its sub segments.
– Learn about the trends, gaps and opportunities in each of the micro markets.
– Identify major stakeholders, product portfolios and recent developments, and draw a competitive landscape for market leaders.

Intended Audience:

– Biotechnology equipment manufacturers
– Biopharmaceutical manufacturers
– Clinical research institutes
– Contract research organizations

Read more and order at Cell Expansion Technologies and Global Markets

Global Microarray Market 2016-2020 – Biotechnology, Healthcare Industries

The Global Microarray Market 2016-2020 Report has been published. It provides updated in 2018 year analysis of industries from Biotechnology, Healthcare Markets.

About Microarray
A microarray is an advanced tool used in molecular biology. It allows end-users to conduct high-throughput and highly parallel analyses of more than thousand points of interest that include messenger ribonucleic acid (mRNA), genes, and proteins. Microarrays include a broad range of platforms in which high-density assays are conducted parallel on a solid support. The concept of the microarray is based on base-pairing hybridization principle (hybridization between nucleic acids).

The analysts forecast the global microarray market to grow at a CAGR of 14.34% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global microarray market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of microarray solutions such as instruments and consumables.

The market is divided into the following segments based on geography:
– Americas
– APAC
– EMEA

The report, Global Microarray Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
– Agilent Technologies
– Illumina
– Thermo Fisher Scientific
– Merck

Other prominent vendors
– Applied Microarrays
– Arrayit
– AXO Science
– BioCat
– BioGenex
– Biometrix Technology
– Cepheid
– GE Healthcare
– InDevR
– LC Sciences
– Perkin Elmer
– Phalanx Biotech
– Qiagen
– Takara Bio
– US Biomax.

Market drivers
– Increased prevalence of chronic diseases
– For a full, detailed list, view the full report

Market challenges
– High cost of instruments
– For a full, detailed list, view the full report

Market trends
– Rising focus on drug discovery and development
– For a full, detailed list, view the full report

Key questions answered in this report
– What will the market size be in 2020 and what will the growth rate be?
– What are the key market trends?
– What is driving this market?
– What are the challenges to market growth?
– Who are the key vendors in this market space?
– What are the market opportunities and threats faced by the key vendors?
– What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.

Read more and order at Global Microarray Market 2016-2020

CAS 2748-02-9 L-Leucine tert-butyl ester hydrochloride Chemical World Report – Biotechnology, Enzymes, Healthcare Industries

The CAS 2748-02-9 L-Leucine tert-butyl ester hydrochloride Chemical World Report Report has been published. It provides updated in 2018 year analysis of industries from Biotechnology, Enzymes, Healthcare Markets.

CAS 2748-02-9 L-Leucine tert-butyl ester hydrochloride Chemical World Report

This CAS 2748-02-9 – L-Leucine tert-butyl ester hydrochloride Chemical World Consumption Report provides data on the net consumption of L-Leucine tert-butyl ester hydrochloride in each of the countries listed. The substance covered (L-Leucine tert-butyl ester hydrochloride) are classified by the Chemical Registry, EC, EU, CAS, or other coding system. In addition, where available this consumption is further analysed by Application or End User sector.

The L-Leucine tert-butyl ester hydrochloride World Consumption Report definitions:

Name: L-Leucine tert-butyl ester hydrochloride
: L-Leucine tert-butyl ester hydrochloride

Chemical Registry number: 769198025366
CAS Number 2748-02-9

The L-Leucine tert-butyl ester hydrochloride Report gives Market Consumption / Products / for over 200 countries by 3 Time series: From 1997- 2016 and Forecasts 2017- 2024 & 2024-2028.

59 Market Research Chapters. Spreadsheet Chapters:

Market Consumption – in US$ by Country by Product by Year.
Market
Financial
Competitive
Market Segmentation
Industry
Critical Parameters
Marketing Costs
Markets
Decision Makers
Performance
Product Launch

World & National Report Market Database & Spreadsheets. Financial Spreadsheets & Databases. Industry Spreadsheets & Databases.

Data includes Market Consumption by individual Product / Service, Per-Capita Consumption, Marketing Costs & Margins, Product Launch Data, Buyers, End Users & Customer Profile, Consumer Demographics. Historic Balance Sheets, Forecast Financial Data, Industry Profile, National Data.

This report consists of a download Zipped file (300-1200MB), plus a DVD, containing the entire report web and databases. The tables & databases are in Access & Excel formats which enable readers to produce their own spreadsheet calculations and modelling. There are five additional DVDs available which provide Ancillary Data, Tools, and Utilities for the analysis and handling of the databases. This database is updated monthly. After-Sales and update services available from The Data Institute.

L-Leucine tert-butyl ester hydrochloride Products/ Markets covered, 2038 pages, 9733 spreadsheets, 9763 database tables, 526 illustrations. Updated monthly. 12 month After-Sales Service.

Read more and order at CAS 2748-02-9 L-Leucine tert-butyl ester hydrochloride Chemical World Report

Norway: Nucleic Acids And Their Salts – Market Report – Analysis And Forecast To 2025 – Biotechnology, Healthcare Industries

The Norway: Nucleic Acids And Their Salts – Market Report – Analysis And Forecast To 2025 Report has been published. It provides updated in 2018 year analysis of industries from Biotechnology, Healthcare Markets.

The report provides an in-depth analysis of the market for Nucleic Acids And Their Salts in Norway. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of key factors influencing the market. Forecasts illustrate how the market will be transformed in the medium term. Profiles of the leading companies and brands are also included.

Countries Coverage: Norway

Product Coverage: Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, except compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused.

Data Coverage:

  • Market volume and value
  • Volume and dynamics of domestic production
  • Key market players and their profiles
  • Exports, imports and trade balance
  • Producer prices, import/export prices
  • Factors influencing the market
  • Forecast of the market dynamics in the medium term
  • Per Capita Consumption

Why Buy This Report??

  • Get the full picture of the market
  • Identify Key success factors on the market
  • Adjust your marketing strategy

Read more and order at Norway: Nucleic Acids And Their Salts – Market Report – Analysis And Forecast To 2025

Stem Cells in Toxicology and Medicine – Biotechnology, Healthcare, Stem Cells Industries

The Stem Cells in Toxicology and Medicine Report has been published. It provides updated in 2018 year analysis of industries from Biotechnology, Healthcare, Stem Cells Markets.

A comprehensive and authoritative compilation of up–to–date developments in stem cell research and its use in toxicology and medicine

  • Presented by internationally recognized investigators in this exciting field of scientific research
  • Provides an insight into the current trends and future directions of research in this rapidly developing new field
  • A valuable and excellent source of authoritative and up–to–date information for researchers, toxicologists, drug industry, risk assessors and regulators in academia, industry and government

Read more and order at Stem Cells in Toxicology and Medicine

Global and Chinese Protein Hydrolysis Enzymes Industry – 2017 – Biotechnology, Enzymes, Healthcare Industries

The Global and Chinese Protein Hydrolysis Enzymes Industry – 2017 Report has been published. It provides updated in 2018 year analysis of industries from Biotechnology, Enzymes, Healthcare Markets.

The 'Global and Chinese Protein Hydrolysis Enzymes Industry – 2017' is a professional and in-depth study on the current state of the global Protein Hydrolysis Enzymes industry with a focus on the Chinese market. The report provides key statistics on the market status of the Protein Hydrolysis Enzymes manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2012-2017 market shares for each company.

Through the statistical analysis, the report depicts the global and Chinese total market of the Protein Hydrolysis Enzymes industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2017-2022 market development trends of the Protein Hydrolysis Enzymes industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.

In the end, the report makes some important proposals for a new project of the Protein Hydrolysis Enzymes Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2012-2022 global and Chinese Protein Hydrolysis Enzymes industry covering all important parameters.

PLEASE NOTE: This report will be completed after order and will take approximately 2-3 business days after the confirmation of payment.

Read more and order at Global and Chinese Protein Hydrolysis Enzymes Industry – 2017